Drug Side Effects
Search
EMBRYONAL RHABDOMYOSARCOMA
EMBRYONAL RHABDOMYOSARCOMA
was reported 52 times
These drug classes are most commonly taken by patients reporting EMBRYONAL RHABDOMYOSARCOMA:
#
Drug
Count
0
Alkylating Drug [EPC]
10
1
CD52-directed Cytolytic Antibody [EPC]
10
2
Folate Analog Metabolic Inhibitor [EPC]
7
3
Platinum-based Drug [EPC]
7
4
Actinomycin [EPC]
5
5
Calcineurin Inhibitor Immunosuppressant [EPC]
5
6
Corticosteroid [EPC]
5
7
Microtubule Inhibitor [EPC]
5
8
Serotonin-3 Receptor Antagonist [EPC]
3
9
Antimetabolite [EPC]
2
10
Interleukin-12 Antagonist [EPC]
2
11
Interleukin-23 Antagonist [EPC]
2
12
Purine Antimetabolite [EPC]
2
13
Recombinant Human Growth Hormone [EPC]
2
14
Tumor Necrosis Factor Blocker [EPC]
2
15
Vitamin B12 [EPC]
2
16
Vitamin C [EPC]
2
17
Vitamin D [EPC]
2
18
Acetylcholine Release Inhibitor [EPC]
1
19
Aminosalicylate [EPC]
1
20
Antimetabolite Immunosuppressant [EPC]
1
21
Leukocyte Growth Factor [EPC]
1
22
Loop Diuretic [EPC]
1
23
Neuromuscular Blocker [EPC]
1
24
Nucleoside Metabolic Inhibitor [EPC]
1
25
Proton Pump Inhibitor [EPC]
1
26
Thrombopoietin Receptor Agonist [EPC]
1
27
Vascular Endothelial Growth Factor Inhibitor [EPC]
1